In the BioHarmony Drug Report Database
Cafcit, Nymusa, Peyona (caffeine, citrated) is a small molecule pharmaceutical. Caffeine, citrated was first approved as Cafcit on 1999-09-21. It has been approved in Europe to treat apnea. The pharmaceutical is active against adenosine receptor A2a, adenosine receptor A3, adenosine receptor A2b, and adenosine receptor A1.
Image (chem structure or protein)